Tracy Woody

Tracy Woody

Director/Miembro de la Junta en
Shorla Pharma Ltd.
.

Fortuna: 105 062 $ al 31/05/2026

56 años
Health Technology
Consumer Services
Health Services

Perfil

Tracy M.
Woody
is currently a Non-Executive Director at Shorla Pharma Ltd. since 2020.
Former positions include Chief Executive Officer at Retroject, Inc. from 2013 to 2015, Managing Director at Tmw Consulting, Inc. from 2013 to 2015, Independent Non-Executive Director at Esperion Therapeutics, Inc. from 2019 to 2026, Chief Commercial Officer at Zevra Therapeutics, Inc. from 2015 to 2016, Executive Vice President-Commercial Strategy at Protagonist Therapeutics, Inc. from 2020 to 2022, Chief Commercial Officer at Versartis, Inc. from 2017 to 2018, Chief Commercial Officer at Aravive, Inc. from 2017 to 2018, Director at ALZA Corp., Senior Manager-Marketing at Pfizer Inc., Vice President-Sales & Marketing at NextWave Pharmaceuticals, Inc., and Vice President-Business Development at Greer Laboratories, Inc. Education includes undergraduate studies at East Carolina University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2026 33.566 ( 0,01 % ) 105 062 $ 31/05/2026

Cargos activos de Tracy Woody

EmpresasCargoInicio
Director/Miembro de la Junta 10/11/2020

Antiguos cargos conocidos de Tracy Woody.

EmpresasCargoFin
ESPERION THERAPEUTICS, INC. Director/Miembro de la Junta 28/05/2026
PROTAGONIST THERAPEUTICS, INC. Corporate Officer/Principal 01/09/2022
Corporate Officer/Principal 12/10/2018
ARAVIVE, INC. Corporate Officer/Principal 12/10/2018
ZEVRA THERAPEUTICS, INC. Corporate Officer/Principal 15/09/2016
Ver el detalle de la experiencia de Tracy Woody.

Formación de Tracy Woody.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

34

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN